Dobutamine-atropine stress echocardiography and dipyridamole sestamibi scintigraphy for the detection of coronary artery disease: Limitations and concordance
Sc. Smart et al., Dobutamine-atropine stress echocardiography and dipyridamole sestamibi scintigraphy for the detection of coronary artery disease: Limitations and concordance, J AM COL C, 36(4), 2000, pp. 1265-1273
Citations number
42
Categorie Soggetti
Cardiovascular & Respiratory Systems","Cardiovascular & Hematology Research
OBJECTIVES We sought to compare dobutamine-atropine stress echocardiography
(DASE) and dipyridamole Technetium 99-m (Tc-99m) sestamibi single photon e
mission computed tomography (SPECT) scintigraphy (DMIBI) for detecting coro
nary artery disease (CAD).
BACKGROUND Both DASE and DMIBI are effective for evaluating patients for CA
D, but their concordance and limitations have not been directly compared.
METHODS To investigate these aims, patients underwent multistage DASE, DMIB
I and coronary angiography within three months. Dobutamine-atropine stress
echocardiography and stress-rest DMIBI were performed according to standard
techniques and analyzed for their accuracy in predicting the extent of CAD
. Segments were assigned to vascular territories according to standard mode
ls. Angiography was performed using the Judkin's technique.
RESULTS The 183 patients (mean age: 60 +/- 11 years, including 50 women) co
nsisted of 64 patients with no coronary disease and 61 with single-, 40 wit
h two- and 18 with three-vessel coronary disease. Dobutamine-atropine stres
s echocardiography and DMIBI were similarly sensitive (87%, 104/119 and 80%
, 95/119, respectively) for the detection of CAD, but DASE was more specifi
c (91%, 58/64 vs. 73%, 47/64, p < 0.01). Sensitivity was similar for the de
tection of CAD in patients with single-vessel disease (84%, 51/61 vs. 74%,
45/61, respectively) and multivessel disease (91%, 53/58 vs. 86%, 50/58, re
spectively). Multiple wall motion ai,normalities and perfusion defects were
similarly sensitive for multivessel disease (72%, 42/58 vs. 66%, 38/53, re
spectively), but, again, DASE was more specific than DMIBI (95%, 119/125 vs
. 76%, 95/125, respectively, p < 0.01). Dobutamine-atropine stress echocard
iography and DMIBI were moderately concordant for the detection and extent
of CAD (Kappa 0.47, p < 0.0001) bur were only fairly (Kappa 0.35, p < 0.001
) concordant for the type of abnormalities (normal, fixed, ischemia or mixe
d).
CONCLUSIONS Dobutamine-atropine stress echocardiography and DMIBI were comp
arable tests for the detection of CAD. Both were very sensitive for the det
ection of CAD and moderately sensitive for the extent of disease. The only
advantage of DASE was greater specificity, especially for multivessel disea
se. Dobutamine-atropine stress echocardiography may be advantageous in pati
ents with lower probabilities of CAD. CT Am Coil Cardiol 2000;36: 1265-73)
(C) 2000 by the American College of Cardiology.